Mayne Pharma receives $14.4m for legal costs from Cosette
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Mayne Pharma Group Ltd. has announced the receipt of a payment from Cosette Pharmaceuticals for legal costs related to a court case. The total amount received is for the recovery of legal costs and associated expenses following a favorable court ruling against Cosette. This payment marks a significant milestone in ongoing legal proceedings initiated by Mayne Pharma against Cosette regarding a terminated agreement. The court had previously dismissed all claims made by Cosette, ordering them to cover Mayne Pharma's legal costs.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26
Mayne Pharma Group Ltd. on 6ix
In the deck
Story so far
Earlier from Mayne Pharma
- Court awards MYX $13.27m for legal costs from Cosette
- Mayne Pharma reports unaudited 3Q FY26 results
- S&P DJI Announces March 2026 Quarterly Rebalance
- Mayne Pharma management changes
- 2026 Half Year Investor Presentation
Later from Mayne Pharma
- Mayne Pharma reports unaudited Q4 and FY26 results
- Mayne Pharma to present at the 20th Bioshares Summit
- Non-Executive Director appointment
- Notification regarding unquoted securities - MYX
- Notification of cessation of securities - MYX
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma